Association of Biologic Prescribing for Inflammatory Bowel Disease With Industry Payments to Physicians

Rishad Khan; Cameron M Nugent; Michael A Scaffidi; Nikko Gimpaya; Samir C Grover

doi:10.1001/jamainternmed.2019.0999

Association of Biologic Prescribing for Inflammatory Bowel Disease With Industry Payments to Physicians

JAMA Intern Med. 2019 Oct 1;179(10):1424-1425. doi: 10.1001/jamainternmed.2019.0999.

Authors

Rishad Khan¹, Cameron M Nugent², Michael A Scaffidi¹, Nikko Gimpaya¹, Samir C Grover¹

Affiliations

¹ Division of Gastroenterology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
² Department of Integrative Biology, University of Guelph, Guelph Ontario, Canada.

Abstract

This economic evaluation examines whether pharmaceutical industry payments to gastroenterologists are associated with how often they prescribe the pharmaceuticals’ drugs for inflammatory bowel disease.